The Ultimate GH Secretagogue Synergy
Optimizing the body’s natural hormonal environment is a cornerstone of advanced physical recovery. Our CJC-1295 (No DAC) + Ipamorelin blend is a meticulously formulated research compound designed to act synergistically on the pituitary gland. By combining a Growth Hormone-Releasing Hormone (GHRH) analogue with a Growth Hormone Secretagogue (GHS), this blend mimics the body’s natural pulsatile release of growth hormone without the constant, unnaturally high levels associated with exogenous injections.
Thank you for reading this post, don't forget to subscribe!How It Works
This blend leverages two distinct pathways to achieve its results:
-
CJC-1295 (No DAC): Functions as a GHRH analogue. It stimulates the pituitary gland to secrete GH. Because this is the “No DAC” version, it has a shorter half-life, which allows for the natural, pulsing release of growth hormone rather than a steady-state spike.
-
Ipamorelin: Functions as a selective Growth Hormone Secretagogue. It triggers the release of GH by mimicking the ghrelin hormone, but crucially, it does not significantly increase hunger or cortisol levels (unlike other ghrelin mimetics).
-
The Synergy: When combined, CJC-1295 and Ipamorelin create a much stronger GH pulse than either compound could achieve alone. This is often referred to as “potentiating” the effect, providing a more efficient recovery signal to the body.
What to Expect
Research subjects typically utilize this blend to support:
-
Improved Sleep Architecture: Many report deeper, more restorative REM sleep cycles.
-
Enhanced Recovery: Accelerated repair of connective tissues and lean muscle after resistance training.
-
Fat Metabolism: Aiding in the optimization of body composition by facilitating the utilization of stored fat for fuel.
-
Anti-Aging Markers: Improved skin elasticity and general vitality.
Side Effects & Management
While generally well-tolerated, the increased GH pulsatility can cause minor, transient side effects:
-
Headaches: Often occurring shortly after administration due to the rapid influx of GH. Management: Start with a lower dosage to allow the pituitary to acclimate.
-
Flushing/Warmth: A brief sensation of heat (especially in the face) shortly after injection. This is a common systemic response to GH secretagogues.
-
Injection Site Irritation: Minor redness or itching. Management: Ensure the injection site is clean and rotated properly; ensure the peptide is reconstituted with bacteriostatic water appropriately.
-
Water Retention: Some may experience mild bloating as the body adjusts to hormonal changes.
Dosage & Protocol (For Research Purposes)
Consistency is key with this blend to mimic natural biological rhythms.
-
Standard Research Dosage: 100mcg of CJC-1295 + 100mcg of Ipamorelin per injection.
-
Frequency: Most research protocols suggest 1 to 2 injections daily.
-
Timing: Administration is commonly performed immediately before sleep or in the morning on an empty stomach (at least 30-60 minutes before food) to maximize the natural GH release peak.
-
Administration: Subcutaneous injection (usually into the abdominal fat).
-
Storage: Keep the lyophilized powder in a cool, dark place. Once reconstituted, it must be stored in the refrigerator.
Formulation Breakdown
This vial contains a combined total of 10mg of active peptide:
-
CJC-1295 (No DAC): 5mg
-
Ipamorelin: 5mg
This allows for a precise 1:1 ratio during reconstitution, making it easy to calculate your research dosage.
Disclaimer
For research purposes only. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before beginning any peptide protocol. Not for human consumption.
